VNV Global's Nomination Committee
VNV Global AB (publ) (“VNV Global” or the “Company”) today announces the composition of the Nomination Committee for the 2027 Annual General Meeting (the “2027 AGM”).
The Nomination Committee has been appointed in accordance with the principles resolved by the AGM held on May 12, 2026.
The members of the Nomination Committee are:
- Johan Malm, appointed by E. Öhman J:or Aktiebolag, Chairman
- Jake Hennemuth, appointed by Acacia Partners
- Cecilia Lundberg, appointed by Lorito SPV Floreal S.à.r.l.
- Lars-Åke Norling, Chairman of the Board (non-voting member)
The Nomination Committee’s task is to prepare and present proposals to the 2027 AGM regarding:
(i) election of the Chairman of the 2027 AGM,
(ii) election of members of the Board of Directors,
(iii) election of the Chairman of the Board of Directors,
(iv) remuneration to the Directors of the Board,
(v) election of the Company’s auditors,
(vi) compensation to the Company’s auditors, and
(vii) to the extent deemed necessary, amendments to principles for how to conduct the nomination process for the 2028 AGM.
Shareholders who wish to submit proposals to the Nomination Committee for consideration at the 2027 AGM are invited to contact the Committee via email at nominationcommittee@vnv.global.
For further information please contact:
Björn von Sivers, CFO
Telephone: +46 8 545 015 50
Email: bjorn@vnv.global
About Us
VNV Global brings together patient capital and network effect businesses to achieve the scale that drives profitability over the long term. We are opportunistic investors in business models that build strong moats. The common shares of VNV Global are listed on Nasdaq Stockholm, Mid Cap segment, with the ticker VNV. For more information on VNV Global, visit www.vnv.global.